financetom
Business
financetom
/
Business
/
Update: Coinbase Q2 Adjusted Earnings, Revenue Miss Expectations; Shares Down Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Coinbase Q2 Adjusted Earnings, Revenue Miss Expectations; Shares Down Pre-Bell
Aug 1, 2025 3:15 AM

05:49 AM EDT, 08/01/2025 (MT Newswires) -- (Updates with the stock price movement in the headline and the last paragraph.)

Coinbase Global ( COIN ) reported Q2 adjusted earnings late Thursday of $0.12 per diluted share, down from $1.10 a year earlier.

Analysts surveyed by FactSet expected $1.25.

Revenue in the three months ended June 30 rose to $1.5 billion from $1.45 billion a year earlier.

Analysts polled by FactSet expected $1.59 billion.

The company's shares were down nearly 12% in recent premarket activity Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AstraZeneca Unusual Options Activity
AstraZeneca Unusual Options Activity
Feb 6, 2025
Financial giants have made a conspicuous bullish move on AstraZeneca ( AZN ). Our analysis of options history for AstraZeneca ( AZN ) revealed 11 unusual trades. Delving into the details, we found 63% of traders were bullish, while 18% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $320,360, and 5...
Brazil to push social diversity as criteria for sustainable investments at COP30
Brazil to push social diversity as criteria for sustainable investments at COP30
Feb 6, 2025
BRASILIA, Feb 6 (Reuters) - Brazil plans to propose social diversity as a global criteria for labeling sustainable investments at the U.N. climate summit it will host this year, a senior official said on Wednesday, despite rising resistance to diversity goals in some corners. Cristina Reis, deputy secretary for sustainable economic development at Brazil's Finance Ministry, told Reuters that the...
Linde Q4: Revenue Misses, EPS Tops, Shares Dip on Soft Guidance
Linde Q4: Revenue Misses, EPS Tops, Shares Dip on Soft Guidance
Feb 6, 2025
Linde PLC ( LIN ) shares are trading lower after the company reported fourth-quarter FY24 results. Sales rose 5% Y/Y to $8.28 billion, underlying sales up 2% Y/Y, missing the consensus of $8.39 billion.  Americas sales rose 1% Y/Y to $3.61 billion, APAC (Asia Pacific) sales increased 2% Y/Y to $1.67 billion and, EMEA (Europe, Middle East & Africa) sales was down 2% Y/Y to $2.06 billion in the quarter. Linde Engineering sales stood at $628 million, down 5% Y/Y, in the quarter. Adjusted...
Eton Pharmaceuticals Says ET-400 FDA Decision Delayed to May
Eton Pharmaceuticals Says ET-400 FDA Decision Delayed to May
Feb 6, 2025
10:14 AM EST, 02/06/2025 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) said Thursday that the US Food and Drug Administration has extended the review deadline for Eaton's new drug application for ET-400, its proprietary patented formulation of hydrocortisone oral solution. The new Prescription Drug User Fee Act goal date is May 28. The FDA informed Eton that more time...
Copyright 2023-2026 - www.financetom.com All Rights Reserved